Seeing Is Believing

Currently out of the existing stock ratings of Ashik Kurian, 15 are a BUY (75%), 5 are a HOLD (25%).
Analyst Ashik Kurian, currently employed at CITI, carries an average stock price target met ratio of 45.83% that have a potential upside of 18.15% achieved within 248 days. Previously, Ashik Kurian worked at JEFFERIES, STEPHENS.
Ashik Kurian’s has documented 38 price targets and ratings displayed on 4 stocks. The coverage is on the Consumer Cyclical sector.
Most recent stock forecast was given on MRSN, Mersana Therapeutics at 27-Jul-2023.
Analyst best performing recommendations are on VNE (VEONEER).
The best stock recommendation documented was for GT (GOODYEAR TIRE & RUBBER CO) at 3/30/2020. The price target of $7.5 was fulfilled within 10 days with a profit of $1.58 (26.69%) receiving and performance score of 26.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Jun-2025
$146
$30.01 (25.87%)
$147
8 days ago
(12-Oct-2026)
0/7 (0%)
$36.24 (33.02%)
Buy Since 21-Apr-2022
$137
27 days ago
(23-Sep-2026)
23/24 (95.83%)
$23.99 (21.23%)
500
Buy Since 06-Mar-2025
$137
$21.01 (18.11%)
$148
1 months 12 days ago
(08-Sep-2026)
30/37 (81.08%)
$16.75 (13.93%)
487
Hold Since 13-Dec-2023
$122
$2.83 (2.37%)
$113
3 months 25 days ago
(25-Jun-2026)
34/37 (91.89%)
$1.19 (0.99%)
233
Hold Since 15-Jun-2026
$122
$2.83 (2.37%)
$124
4 months 5 days ago
(15-Jun-2026)
5/5 (100%)
$-3.79 (-3.01%)
144
What Year was the first public recommendation made by Ashik Kurian?